An observational study in Coronary Disease, Peripheral Arterial Disease and Collateral Circulation, Any Site, sponsored by Jung-min Ahn. Recruiting at 1 site in Korea, Republic of. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2021-09-14.
Sponsored by Jung-min Ahn · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 49 studies in Coronary Disease with a site in Korea, Republic of — 6 open to participants now, 7 under way, none of them phase 3. Coronary Disease · Korea, Republic of.
Among the 49 studies in Coronary Disease with a site in Korea, Republic of, this one is the 14th largest by planned enrollment of the 20 observational ones that give a count, is one of 3 that started in 2015, is one of 20 observational ones, and was the 46th registered.
1,522 studies on the registry are indexed under Coronary Disease; 167 are open to participants now.
Browse Coronary Disease studies →6 of the 49 studies in Coronary Disease with a site in Korea, Republic of are open now. Recruiting first, the newest first:
Seung-Whan Lee, M.D., Ph.D. · Sites in Korea, Republic of
Ages 19+
Jung-min Ahn · Sites in Korea, Republic of
Ages 19+
Seung-Jung Park · Sites in Korea, Republic of
Ages 19+
Young-Hak Kim, MD, PhD · Sites in Korea, Republic of
Ages 20+
Seung-Jung Park · Sites in Korea, Republic of
Ages 19+
A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →
Of the 106 Coronary Disease studies recruiting now, 64 (60%) set no upper age limit and 19 (18%) stop at 75 or younger; 8 take children under 18; 10 take healthy volunteers.
This study: 20 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
49 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 3 started in 2015.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 400 is below the median of 916 across 478 observational studies indexed under Coronary Disease.
Median enrollment 1,000 across the 29 interventional studies, 1,125 across the 20 observational. Of the 34 that completed or were terminated, 7 (21%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 49 have an industry lead sponsor. The 10 most frequent:
Jung-min Ahn is the lead sponsor of 7 studies on the registry; 4 are open to participants now.
Jung-min Ahn has 3 studies filed under Coronary Disease — fewer than ten, so there is no comparison to draw.
2 of the studies in Coronary Disease with a site in Korea, Republic of that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05044273Jung-min AhnEvaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent | 2026-12-31 |
| NCT05529459Seung-Whan Lee, M.D., Ph.D.Anatomic Versus Physiologic Guidance for Complete Revascularization With DES Eluting in Patients With CAD | 2026-12-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 49 studies in Coronary Disease with a site in Korea, Republic of, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to evaluate the genome-wide association for the development of collateral circulation for patients with coronary or peripheral artery disease and to develop the molecular genetic treatment model based on genome-wide association data.
Patients with chronic total coronary or peripheral occlusion
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Diagnostic Test: Blood samples
Diagnostic Test: Blood samples
Diagnostic Test: Blood samples
Diagnostic Test: Blood samples
for evaluation of the genome-wide association study
Correlation between genome and collateral flow
Time frame: 5 years
Plan to share: Undecided
No publications or documents are linked to this record.
Started Aug 2015 (actual). Primary completion is estimated for Jun 2025, 118 months after the start.
Of 132 non-industry observational studies under Coronary Disease, half reached primary completion within 59 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 192. This study's planned 118 months is above that.
Counting every sponsor, half of 154 studies reached it within 47 months; a quarter within 21 and three quarters within 123.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Jung-min Ahn